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The deleterious consequences of sustained ischemia, however, are not restricted to the myocytes. For example, a mild progressive decrease in resting myocardial perfusion, called "low reflow," has been observed in viable previously ischemic tissue during the initial hours after restoration of blood flow.14-'8 In addition, the ischemic/reperfused region exhibits a progressive decrease in endothelium-dependent and endotheliumindependent coronary vasodilator reserve; that is, a reduction in the capacity for increased myocardial blood flow in response to metabolic or pharmacological stimuli. [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] Do the benefits of ischemic preconditioning extend beyond the myocyte and protect vascular endothelium from injury and dysfunction after subsequent sustained occlusion/reperfusion? With the exception of two previous studies,13'31 virtually all preconditioning protocols have focused on the concept of infarct size limitation; the effects of ischemic preconditioning on the coronary vasculature remain poorly understood. Thus, our objective in the present study was to determine whether ischemic preconditioning would attenuate low reflow and blunt the loss of vasodilator reserve after 60 minutes of sustained coronary occlusion in the anesthetized canine model.
Methods
This study was approved by the Institutional Animal Care and Use Committee of the Hospital of the Good Samaritan (an AAALAC-accredited institution) and conforms to the Position of the American Heart Association on Research Animal Use (Circulation. 1985 ;71:849).
Surgical Preparation
Fifty mongrel dogs weighing between 16 and 29 kg were lightly sedated with morphine sulfate (15 mg SC) and anesthetized with sodium pentobarbital (30 mg/kg IV). The dogs were then intubated and ventilated with room air. After the left jugular vein was cannulated for administration of drugs and fluid and the carotid artery cannulated for measurement of systemic hemodynamic parameters, the heart was exposed by a left lateral thoracotomy through the fifth intercostal space and suspended in a pericardial cradle. A fluid-filled catheter was inserted in the left atrium for later injection of radiolabeled microspheres for measurement of regional myocardial blood flow (RMBF). A segment of the left anterior descending coronary artery (LAD) was isolated, usually just distal to its first major diagonal branch, for later placement of occlusive vascular clamps, and a second segment of the LAD was isolated for placement of a Doppler ultrasonic flow probe for measurement of mean coronary blood flow (CBF). Arterial pressure and CBF were monitored continuously throughout each experiment with a Gould recorder.
Protocol 1: Vasodilators Administered Before and After Sustained Occlusion
After baseline measurements of hemodynamic parameters, CBF, and vasodilator reserve (the details of which are described below) were obtained, the first 18 dogs in the study were randomly assigned to either the preconditioned group or the control group. Animals in the preconditioned group underwent four repeated 5-minute LAD occlusions, each separated by 5 minutes of reflow. The LAD was then occluded for 1 hour and reperfused for 4 hours. This preconditioning regimen was chosen on the basis of previous studies in the canine model in which four episodes of 5-minute circumflex coronary occlusion effectively limited infarct size caused by a subsequent 40-minute period of sustained circumflex occlusion.1 Dogs in the control group also underwent 1 hour of LAD occlusion and 4 hours of reperfusion but received no intervention during the 40 minutes before sustained ischemia. To control the incidence of lethal arrhythmias, lidocaine (1.5 mg/kg IV) was administered to all dogs before the first brief occlusion (preconditioned group only), before the sustained oc- clusion, and at the time of sustained reperfusion. Dogs that developed ventricular fibrillation were not resuscitated. Hemodynamic parameters and CBF were monitored during each brief occlusion/reperfusion (preconditioned group only), throughout sustained LAD occlusion, and at frequent intervals after sustained reflow.
Regional Area at risk and infarct size. After fixation, right ventricular tissue was trimmed from each heart slice, and the remaining left ventricular tissue was weighed. Photographic images of the heart slices were projected and traced at magnifications of approximately x 2 to x 4. Extent of the AR and AN in each heart slice were quantified by computerized planimetry, corrected for the weight of the tissue slice, and summed for each heart. AN was then expressed as a percentage of the AR.
Regional myocardial blood flow. After the left ventricular weight had been obtained, tissue blocks were cut from the center of the previously ischemic LAD bed and remote, normally perfused circumflex bed and subdivided into subendocardial, midmyocardial, and subepicardial segments. RMBF was then quantified by the method of Domenech et al.34 Histology (protocols 1 and 2 only). Additional tissue blocks were cut from the center of the LAD bed and the remote circumflex region. After routine histological processing, 5 ; Fig 1, A) . Subepicardial RMBF during LAD occlusion, however, was higher in the control group than in preconditioned dogs (P<.05; Fig 1, B) emia/reperfusion observed in one control animal in the study. Before randomization, injection of acetylcholine increased CBF from a baseline value of 9.5 mL/min to 25.5 mL/min, and challenge with nitroglycerin increased CBF to 15.5 mL/min. At 30 minutes after reflow, the responses to acetylcholine and nitroglycerin remained essentially unchanged. However, at 4 hours after reperfusion, CBF increased to only 17.0 mL/min and 9.6 mL/min in response to acetylcholine and nitroglycerin, respectively. Table 2 summarizes the mean vasodilator response to acetylcholine for all dogs in protocol 1. The increase in CBF in response to acetylcholine was similar between control and preconditioned groups before randomization and remained unchanged at 30 minutes after sustained reperfusion. A decrease in endothelium-dependent vasodilation, however, was observed at 4 hours after reflow: maximum CBF in response to acetylcholine averaged 18.2±2.1 vs 15.4±1.7 mL/min at 30 minutes vs 4 hours after reperfusion in the control group (P<.05) and 23.6±5.3 vs 15.6±3.5 mL/min in the preconditioned animals (P<.01). There were no significant differences in the response to acetylcholine between the control and preconditioned groups either before randomization, at 30 minutes after reperfusion, or at 4 hours after reflow.
As expected, intravenous injection of acetylcholine also resulted in systemic vasodilation and a subsequent transient decrease (on the order of 20 mm Hg) in mean arterial pressure. Importantly, however, mean arterial pressure during acetylcholine challenge did not differ between 30 minutes and 4 hours after reperfusion in either the control or preconditioned groups.
Changes in the vasodilator response to nitroglycerin challenge followed a time course similar to those observed with acetylcholine (Table 2) . That is, whereas there was no change in endothelium-independent vasodilation at 30 minutes after reperfusion, the response to nitroglycerin decreased during the subsequent 3.5 hours of reflow; specifically, maximum CBF was 15 (Figure 4) .
To confirm that our preconditioning regimen truly protected the myocytes from subsequent ischemia, infarct size was assessed in all dogs. Surprisingly, however, all dogs in protocol 1 had negligible infarcts, with AN averaging only 3±1% and 2±1% of the AR in the control and preconditioned dogs, respectively (P=NS). Furthermore, when infarct size was plotted as a function of collateral blood flow during sustained LAD occlusion for the 11 dogs in which paired data were obtained (Fig 4, A) , the expected inverse relation between these two variables was not seen in the control group; even the most severely ischemic control animals exhibited virtually no necrosis. Infarct size in all dogs was similar to data reported for preconditioned groups in previous studies1,3,4 and considerably Of the 23 dogs entered into protocol 2, three animals (two control, one preconditioned) died of ventricular fibrillation during sustained LAD occlusion. In addition, one preconditioned animal died during the first brief occlusion, and one preconditioned dog fibrillated at the time of reperfusion. Thus, a total of 18 dogs -7 control and 11 preconditioned-are included in the analysis of protocol 2.
Hemodynamics. Heart rate and mean arterial pressure did not differ between the two groups at any time during protocol 2 ( min' -g1 (Fig 1, C) .
When all dogs in protocol 2 were considered, subendocardial RMBF at 30 minutes after reperfusion was restored to 1.84±0.50 mL* minm g`in control animals vs 0.74+0.08 mL* min'* g`1 in the preconditioned group (P<.05). Furthermore, this significant difference in blood flow during early reperfusion persisted when all six dogs with high collateral flow were excluded from analysis (2.05±0.53 vs 0.70±12 mL. min-l g`1 in the six control vs six preconditioned dogs that exhibited severe ischemia; P<.05). Thus, in all dogs, subendocardial blood flow measured early after reperfusion was significantly greater in control animals than in those preconditioned before sustained ischemia (Fig 1, C) . This difference, however, was limited to the subendocardium: subepicardial RMBF was similar in both control and preconditioned dogs at 30 minutes after reperfusion (Fig 1, D) .
As in protocol 1, all dogs in the second limb of the study exhibited low reflow. Specifically, subendocardial RMBF deteriorated to 0.55±0.11 and 0.50±0.06 mL *minl* g1 during the subsequent 3.5 hours of reflow in the control and preconditioned groups, respectively (P<.05 vs corresponding value at 30 minutes after reflow for both groups; P=NS between groups). This deterioration in flow was not mediated by the degree of collateral perfusion: when dogs with high collateral flow were excluded, subendocardial RMBF at 4 hours after reperfusion was 0.57±0.13 and 0.53±0.06 mL-min'k gì n the control and preconditioned groups, respectively. Thus, despite a difference in flow at 30 minutes after reperfusion, RMBF decreased in all dogs between 30 minutes and 4 hours after reflow and decreased to the same values at 4 hours after reflow in both the control and preconditioned groups.
As in protocol 1, evidence of low reflow was also apparent from the significant decrease in CBF observed in both groups between 30 minutes and 4 hours after reperfusion (Table 4 ). Most importantly, there were no significant differences in the response to acetylcholine or nitroglycerin between control and preconditioned groups either at 30 minutes after reperfusion or at 4 hours after reflow (Table 5) .
Histology. None of the dogs in protocol 2 exhibited evidence of hemorrhage (Table 6 ). Edema was evident in 17 of 18 hearts, with no significant difference in intracellular or interstitial edema between the two groups.
Area at risk and infarct size. When all dogs in protocol 2 were considered, AN averaged 2+1% of the risk region in the preconditioned group, significantly smaller than the value of 11±3% observed in control animals (P<.01). However, interpretation of these infarct size data is confounded by the high collateral blood flow and smaller risk regions in the preconditioned group vs the (Fig 4, B) . Furthermore, the regression line for the preconditioned animals fell below that for the control group, indicating that, for any level of collateral blood flow, infarct size was smaller in preconditioned animals than in controls. In fact, ANCOVA revealed a significant difference in this relation for control vs 
Protocol 4: Sham-Operated Controls
One sham-operated control was excluded from analysis because of respirator failure (and hypoxia) during the protocol; thus, results are presented from the remaining two animals ( Table 8) .
Mean arterial pressure in the two sham-operated controls decreased during the protocol, averaging 120+13, 121+4, and 107+0 mm Hg at baseline and 30 minutes and 4 hours after "reperfusion," respectively. In addition, the sham-operated dogs developed no loss in vasodilator reserve. Injection of acetylcholine increased CBF from a baseline value of 12.5+±1.5 mL/ min to 31.3±1.3, 28.9+0.9, and 29.5±0.3 mL/min before "occlusion" and 30 minutes and 4 hours after "reflow," respectively. Similarly, the response to nitroglycerin remained essentially unchanged. Mean arterial pressure during the three repeated drug injections did, however, tend to decrease during the protocol for both acetylcholine (103±8, 99±13, and 90±3 mm Hg) and nitroglycerin (106±13, 99±4, and 91±3 mm Hg).
Not surprisingly, neither sham-operated animal showed any evidence of infarction by triphenyltetrazolium chloride staining.
Discussion
In this study, we report that the well-documented cardioprotective effects of ischemic preconditioning on the myocyte do not extend to the coronary vasculature in this canine model. Despite the expected reduction in infarct size with preconditioning observed in the second limb of our study, preconditioning did not attenuate the decrease in resting myocardial blood flow or the deterioration in submaximal vasodilator reserve observed between 30 minutes and 4 hours of reperfusion in the anesthetized open-chest dog.
Coronary Vasodilator Reserve
Sustained ischemia/reperfusion results in a loss in coronary vasodilator reserve; this has been extensively documented both in isolated arterial rings previously exposed to ischemia19-24 and in in vivo models of coronary artery occlusion followed by reperfusion. 17, 18, [25] [26] [27] [28] [29] What duration of ischemia is necessary to precipitate these abnormalities in vascular reactivity after reflow? Although most of these previous studies have involved 1 hour or more of sustained coronary occlusion, even a 15-minute episode of sustained ischemia has been shown to impair vascular reactivity during the initial hours after reperfusion. '7,19 20 Results obtained after 10 minutes of sustained coronary occlusion, however, are inconclusive: one study has described subtle abnormalities in coronary reactivity,18 yet others have found that 10 minutes of sustained ischemia did not alter endothelium-dependent or endothelium-independent vasodilator reserve.38,39 Interestingly, neither 12 repeated episodes of 5 minutes of coronary occlusion plus 10 minutes of reperfusion40 nor three episodes of 10 minutes of occlusion plus 30 minutes of reperfusion41 impaired coronary vasodilator reserve during subsequent sustained reperfusion. Similarly, our data from protocol 3 indicate that four episodes of brief 5-minute coronary occlusion (ie, our preconditioning regimen) did not compromise vascular reactivity. These results indicate that repeated short (<10-minute) episodes of transient ischemia interrupted by transient reflow do not impair vasodilator reserve. Rather, it appears that > 10 minutes of sustained ischemia is needed to initiate subsequent abnormalities in vasodilator reserve.
Although there is no doubt that 1 hour or more of sustained ischemia results in a loss in coronary vasodilator reserve, the precise time course of this deterioration in vascular reactivity is uncertain. Impaired vasodilator reserve has, in some cases, been observed early (ie, within the initial 2.5 minutes22,23 to 1 hour26-28) after relief of sustained ischemia. In contrast, our present study and others25,29 found essentially normal vasodilator reserve during the initial 30 minutes after reperfusion, with deterioration during the subsequent hours after reflow. This difference among studies may be explained by the results of Vanhaecke et a125: these authors observed that vasodilator reserve in regions of viable myocardium was preserved at the onset of reperfusion but was depressed at 2.5 hours after reflow; in contrast, in necrotic myocardium, the loss in vasodilator reserve was apparent at the time of reperfusion. Thus, the question of whether abnormalities in vascular reactivity are manifest immediately or progressively after reperfusion may depend on the proportions of necrotic and viable myocardium in the ischemic/reperfused territory.
In any case, results obtained in the present protocol are in general agreement with previous observations, in that 4 (not subjected to coronary occlusion) showed a decrease in arterial pressure with essentially no change in the response to vasodilator challenge. Similarly, it is possible that differences in mean arterial pressure during drug injections may also have contributed to the decrease in vasodilator reserve. However, systemic vasodilation during drug injections remained unchanged between 30 minutes and 4 hours after reperfusion in control animals in both protocols 1 and 2 and thus cannot explain the loss in vascular reactivity observed in these groups. Moreover, the greatest reductions in mean arterial pressure during drug infusions were observed in sham-operated controls (protocol 4), yet the responses to acetylcholine and nitroglycerin did not decrease in these animals between 30 minutes and 4 hours after "reperfusion." The fact that our consistent reductions in vascular reactivity were not accompanied by consistent alterations in mean arterial pressure suggests that the small decrease in perfusion pressure observed in some of our experimental groups did not play a crucial role in our measurement of coronary vasodilator reserve.
Most importantly, we found that preconditioning did not protect against the deterioration in coronary vasodilator reserve after sustained ischemia/reperfusion. In both protocols 1 and 2, the response to acetylcholine and nitroglycerin did not differ between the control and preconditioned groups at any time during the experiment. Furthermore, the responses to acetylcholine and all animals appear to have been "preconditioned") and protocol 2.
Only one previous study has specifically focused on the effects of ischemic preconditioning on coronary vasodilation.31 Specifically, DeFily and Chilian used intravital microscopy to visualize and measure arteriolar diameters on the epicardial surface in anesthetized open-chest dogs. The authors reported that 1 hour of coronary occlusion followed by 90 minutes of reflow significantly attenuated the increase in arteriolar diameter in response to serotonin, an endothelium-dependent vasoactive agent. Serotonin-mediated dilation was preserved, however, in dogs preconditioned with a single 10-minute brief ischemic episode. 31 Since coronary vasodilator reserve at any given perfusion pressure is, in principle, directly proportional to the cross-sectional area of the vascular bed,26'42 the reasons for the apparent discrepancy between our measurements of vascular reserve with acetylcholine and the arteriolar diameter measurements with serotonin are uncertain. Obvious differences in the preconditioning regimen and the choice of test agent may in part account for the discrepancy between the two studies. In particular, the vasoactive effects of serotonin are complex: serotonin has been shown to act as a dilator in vessels in which the endothelium is intact, as a constrictor in vessels with damaged endothelium,19'43 and appears to have a dose-dependent biphasic effect in conscious dogs without endothelial injury.44 It should also be stressed that we did not assess maximal coronary vasodilator reserve: differences between control and preconditioned animals might have become apparent at maximal vasodilation. However, conclusive resolution of this discrepancy awaits concurrent measurement of both arteriolar diameters and CBF.
Low Reflow
In addition to the progressive deterioration in coronary vasodilator reserve, reperfusion after sustained ischemia also results in a reduction in resting myocardial perfusion with respect to baseline, preocclusion values. This deficit in resting perfusion may be a result of two distinct phenomena: "no reflow" and "low reflow."114 Low reflow refers to a mild depression in resting myocardial perfusion (to 65% to 80% of normal values) that occurs in viable myocardium salvaged by reperfusion.14-18 In contrast, no reflow refers to an anatomic perfusion defect -that is, tissue fails to reperfuse -after removal of the coronary artery occlusion. 45 No reflow is characterized by a marked reduction in flow to c35% of normal values14"5 and is associated with severe endothelial injury (often accompanied by hemorrhage). Most importantly, however, no reflow is confined within areas of frankly necrotic myocardium, whereas low reflow occurs in regions of viable myocardium.45 '46 One previous study has specifically assessed the effects of preconditioning on resting myocardial perfusion after relief of ischemia. Using the rabbit model, Hale and Kloner13 reported that transmural myocardial blood flow at 3 hours after reperfusion was significantly higher in preconditioned rabbits than in controls. 13 Infarct size was reduced by preconditioning in this rabbit model (53% vs 30% of the risk region in control nitroglycerin were similar in both protocol 1 (in which vs preconditioned groups), but in contrast to our canine model of subendocardial necrosis, the infarct in both control and preconditioned rabbits involved the subendocardial, mid, and subepicardial layers. Thus, the deficit in myocardial perfusion in this rabbit model represents no reflow, and the attenuation in no reflow associated with preconditioning was a secondary consequence of infarct size reduction. '3 All animals in protocols 1 and 2 of the present study demonstrated a decrease in resting myocardial perfusion in the ischemic/reperfused LAD bed between 30 minutes and 4 hours after reflow. In addition, myocardial blood flow at 4 hours after reperfusion was consistently lower in the ischemic/reperfused LAD bed compared with the normally perfused circumflex bed. The deterioration in flow in the ischemic/reperfused subepicardium clearly represents low reflow. Infarct size even in the most severely ischemic control animals in protocol 2 occupied <25% of the risk region; that is, all infarcts were confined to the subendocardium, and the decrease in subepicardial flow involved only viable tissue. Furthermore, the deterioration in resting myocardial perfusion observed in protocols 1 and 2 was not a consequence of prolonged anesthesia or a reduction in coronary perfusion pressure, since myocardial blood flow in the sham-operated controls remained unchanged between 30 minutes and 4 hours after "reflow."
In contrast, the deterioration in flow in the ischemic/ reperfused subendocardium may represent a mixture of both no reflow (ie, an anatomic perfusion defect within the subendocardial necrosis) and low reflow in the remaining viable tissue. However, the contribution of no reflow in this protocol would appear to be minimal. Although we did not assess the ultrastructure of the myocytes or vasculature in this study, only 1 of the 32 dogs in protocols 1 and 2 showed any histological evidence of hemorrhage (an indicator of vascular injury) within the necrosis. This is in agreement with previous reports that have demonstrated that vascular injury and obstruction, even within necrotic myocardium, occurred only after >60 minutes of ischemia in the canine model.46 In addition, if no reflow were important, we would anticipate that in protocol 2, endocardial blood flow would be lower in control animals than in the preconditioned dogs, simply because of infarct size reduction. This, however, was not the case: endocardial blood flow at 4 hours of reperfusion averaged 0.55 and 0.50 mL min1 . g`1 in the control and preconditioned groups, respectively. Whether the deterioration in subendocardial blood flow represents solely low reflow or a mixture of low reflow and no reflow, the overall conclusion remains unchanged: preconditioning did not attenuate the decrease in resting perfusion observed at 4 hours after reflow in our canine model. The only significant difference between control and preconditioned animals in this study, aside from the expected reduction in infarct size in protocol 2, was the difference in subendocardial blood flow in this second limb of the study at 30 minutes after reperfusion. Specifically, mean resting blood flow in the subendocardium was two to three times higher in control animals than in the preconditioned group (Fig 1, C) . There was no difference in endocardial flow between control and preconditioned groups in protocol 1, presumably because all dogs in the first limb of the study had been "preconditioned."
Although we did not measure myocardial blood flow during the initial minutes after reperfusion, the data at 30 minutes after reflow may indicate that control animals in protocol 2 exhibited a greater magnitude or duration of hyperemia in the subendocardium. Reactive hyperemia has been attributed, at least in part, to accumulation of adenosine during coronary occlusion and subsequent washout of this potent vasodilator on reperfusion.25,26,47 Thus, the increased flow in the control group could reflect prolonged washout of enhanced concentrations of adenosine. However, Kitakaze et al '8 have recently reported the converse: that is, adenosine release was higher in preconditioned dogs than in controls throughout the initial 40 minutes after relief of sustained ischemia. Our results combined with those of Kitakaze et al raise the possibility that the sensitivity of the coronary vasculature to adenosine might be altered with preconditioning, but this hypothesis obviously requires confirmation. In any case, despite the difference in resting subendocardial blood flow at 30 minutes after reperfusion, there was no difference in the deterioration in flow between the control and preconditioned groups during the subsequent 3.5 hours.
Did Preconditioning Alter Blood Flow During Sustained Coronary Occlusion?
Although the differences did not achieve statistical significance, preconditioned dogs in protocol 2 had higher values of RMBF during sustained coronary occlusion than did the controls. This apparently enhanced flow during sustained occlusion could be interpreted as a beneficial effect of preconditioning. In fact, repeated measurement of RMBF in the rabbit indicated that blood flow in preconditioned animals was higher at 35 minutes than at 2.5 minutes of sustained ischemia in this model. 13 This, however, does not appear to be the case in the anesthetized dog: repeated measurement of RMBF revealed no increase in collateral blood flow during the initial 40 minutes of sustained coronary occlusion in the canine model.2 In addition, RMBF measured during the third brief episode of preconditioning ischemia has been shown to be similar to that measured at 30 minutes into the sustained occlusion. 4 Furthermore, this "beneficial" effect of preconditioning on RMBF during occlusion did not occur in protocol 1. We therefore conclude that the higher values of RMBF during occlusion in preconditioned dogs in the second limb of the study was simply a consequence of the well-documented variability in collateral blood flow in the canine model. Did the Vasodilators Given Before Sustained Ischemia 'Precondition' the Myocardium?
In our hands, 1 hour of LAD occlusion in the anesthetized open-chest dog typically results in infarct sizes ranging from approximately 40% of the AR (in dogs with essentially no collateral blood flow) to 0% of the risk region (in dogs with extensive collateral perfusion), with a mean on the order of 10% to 20% of the myocardium at risk. 4, 36, 37 Preconditioning before 1 hour of occlusion in this canine model significantly reduces infarct size for all values of collateral blood flow, to a mean of approximately 5% of the risk region.4 These expected results were observed for control and preconditioned animals in protocol 2. However, an unexpected observation in this study was the uniformly small infarcts observed in protocol 1, even in the most severely ischemic control animals. These data indicate that evaluation of coronary flow reserve with nitroglycerin and/or acetylcholine before sustained ischemia reduced infarct size to an extent similar to that achieved by preconditioning.
Nitroglycerin given before and during coronary occlusion has been reported to reduce infarct size.49 However, the brief injections of nitroglycerin given before occlusion in protocol 1, combined with the short halflife of this agent (on the order of 3 minutes), suggest that the observed infarct size reduction was probably not a result of a direct treatment effect of nitroglycerin. Injection of both acetylcholine and nitroglycerin induced a transient increase, followed by a modest transient decrease, in CBF (Fig 3) . Cyclic variations in CBF (produced by aggregation and dissolution of a platelet thrombus) before sustained ischemia have been shown by our laboratory to precondition the canine myocardium.4 In this previous study, however, the dogs were rendered severely ischemic during the flow variations, with endocardial blood flow at the nadir being reduced to a mean of 0.05 mL * min-1 * g tissue-1. Whether the smaller amplitude of coronary flow variation produced by acetylcholine and nitroglycerin, which did not result in profound myocardial ischemia, is sufficient to induce a cardioprotective effect is unknown. Alternatively, a recent preliminary report has suggested that acetylcholine administered before sustained ischemia in the rabbit model mimics the protective effect of preconditioning (that is, reduces infarct size) by activation of the Gi protein coupled to the A, and muscarinic cholinergic receptors.7
It was not our objective to assess the role of adenosine, the A, receptor, or the Gi protein as the mechanism(s) for infarct size reduction by preconditioning. Our results from protocol 1 indirectly support the concept that acetylcholine-mediated activation of the Gi protein may play a role in the protective effect of preconditioning on the myocytes. However, even if this pathway were to play a role in our canine model, it does not protect against low reflow or the loss in vasodilator reserve after sustained ischemia/reperfusion.
Summary
Ischemic preconditioning protects the myocytes from a subsequent 1-hour episode of sustained coronary artery occlusion by an as yet unknown mechanism. However, results from the present study indicate that the protective effects of this phenomenon do not extend to the coronary vasculature in the anesthetized openchest dog: preconditioning neither prevented the deterioration in resting myocardial blood flow nor blunted the loss in submaximal vasodilator reserve observed between 30 minutes and 4 hours after reperfusion in this canine model.
